News Markets Research

News

Headlines Threads Atlas

© 2026 Araverus

About Contact Privacy Terms

Araverus does not provide financial, investment, or trading advice. All content is for informational purposes only. Full disclaimer

News
/
Markets
/
Deals

AbbVie denial sends Revolution Medicines shares tumbling 14% after initial 29% surge

Araverus Team|Wednesday, January 7, 2026 at 10:44 PM

Araverus Team

Jan 7, 2026 · 10:44 PM

AbbVie · Acquisition Rumors · Revolution Medicines · Stock Volatility

AbbVie Acquisition Rumors Revolution Medicines Stock Volatility

Revolution Medicines' shares surged 29% on reports of an acquisition by AbbVie, but fell 14% after AbbVie denied the talks.

The potential deal could value Revolution Medicines at around $20 billion.

Read More On

Revolution Medicines Draws Takeover Interestwsj.com

A Look At Revolution Medicines (RVMD) Valuation After Strong Recent Share Price Momentum - Yahoo Financefinance.yahoo.com

Revolution Medicines Stock Drops After-Hours On AbbVie Denying Acquisition Talks - Stocktwitsstocktwits.com

Related Articles

Tech★★★Similarity: 62% · Jan 7

GIC and Coatue Inject $10 Billion, Propelling Anthropic's AI Valuation to $350 Billion

The planned deal represents nearly a doubling of the AI startup’s valuation from four months ago.

Markets★★★Similarity: 59% · Jan 13

Orsted Shares Surge as Judge Clears Path for Revolution Wind Project Restart

Orsted shares jumped Tuesday after a U.S. judge ruled that work could resume at the company’s Revolution Wind project off the coast of Rhode Island.